drugset / Trial / NCT02443285

Is Spontaneous Bacterial Peritonitis Still Responding to 3rd Generation Cephalosporins?

NCT02443285

Phase 3 Unknown 100 enrolled Tanta University
RandomizedParallel-groupDouble-blindTreatment

Summary

Current European and most other international guidelines recommend the use of a third-generation cephalosporin as the first choice, or amoxicillin-clavulanate acid or fluoroquinolones as an alternative choice . These recommendations are based mainly on clinical trials that were very often conducted a decade or more ago, and on the assumption that E. coli would be involved in nearly half of the cases. The microbial etiology of SBP remains relatively constant; however, the antibiotic resistance rate especially for third-generation cephalosporins (including cefotaxime and ceftazidime), ciprofloxacin, and ofloxacin increased dramatically .

Timeline

Start
2015-01
Primary completion
2019-12
Completion
2019-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Cefotaxime Small molecule 2 g
Comparator Ceftriaxone Other / unclassified 2 g